how glp-1 drugs cause gastroparesis lawsuits Manufacturers Argue Should Require Contemporaneous Diagnostic Testing GLP-1 receptor agonists and delayed
Description
After duplicates were removed, 860 were screened, and 54 were selected on the basis of title and abstract evaluation
Clinicians should interpret lower glucose values in the context of semaglutide therapy and adjust diabetes management accordingly
We have to consider GLP-1 drugs longer-term societal impact because they have the potential to be cost-effective years or decades down the line
2,5,8-10,12,13 As research advances, these insights highlight the potential of nutrition science to inform future GLP-1-targeted therapies and sustainable strategies for metabolic health
JACC Heart failure (2023) 11(8 Pt 1):100010
Trnblom H
